Table 1.
Efficacy of various treatment protocols for glioma-bearing animals among different experimental groups
| Group (n) | Median survival (days) | IST median (%) | Mean survival (days) | IST mean (%) | Maximal survival (days) | p-value |
|---|---|---|---|---|---|---|
| Control (12) | 21 | — | 21.5 | — | 28 | — |
| FUS (13) | 23 | 9.5 | 23.9 | 11.2 | 32 | 0.116 |
| IL-12 (12) | 26 | 23.8 | 25.5 | 18.6 | 35 | 0.004 |
| IL-12 + FUS (13) | 30 | 42.9 | 31.2 | 45.1 | 45 | <0.001 |
Increase in median survival time (ISTmedian; in %), mean survival time (ISTmean; in %) and statistical analysis (Log-rank test and p-value) are all relative to the control group (n = number of animals per group).